newsfilter
← Latest News
GlobeNewswire·

Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit

SAN FRANCISCO and WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (NASDAQ:APGE), a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy